We are thrilled to return for another episode of the Life Sciences Today Podcast, brought to you by Healthcare IT Today. Today, I am joined by Engy Ziedan, who is the Co-Founder and Chief Science Officer at Protege. In this episode, I converse with Ziedan about the emerging impact of AI models on care, despite their evaluation primarily relying on static tests that are prone to prompting, tainted by training data, or disjointed from the environments they will operate in.
We delve into her personal experiences, as well as discuss Protege’s value creation, value capture, and competitive advantage. In addition, we discuss the most significant anti-pattern in her field. For this episode of the Life Sciences Today podcast, here are the primary subjects we cover:.
As the Chief Science Officer at Protege, my journey began with a strong passion for science and innovation. Our customers consist of various industries, including biotech, pharmaceutical, and cosmetics. We create value for them by offering cutting-edge technology and specialized services to enhance their research and development processes.
It is widely acknowledged that EMRs are known for their high levels of noise and outdated nature. How do you manage this situation? What are three actions you wish to take for your clients in the coming year?
What is the special ability you possess?
